Tonix Pharmaceuticals Holding Corp. Stock
The sentiment is rather negative at the moment with 16 Sell predictions and 2 Buy predictions.
On the other hand, the target price of 5 € is above the current price of 2.82 € for Tonix Pharmaceuticals Holding Corp., so the potential is actually 77.3%.
Our community identified positive and negative aspects for Tonix Pharmaceuticals Holding Corp. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tonix Pharmaceuticals Holding Corp. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
Ardelyx Inc. | 3.700% | -1.640% | -11.302% | 48.049% | 3.737% | -18.973% | - |
Salarius Pharmaceuticals Inc. | -1.840% | 1.429% | 0.472% | -70.417% | -23.243% | -98.377% | -99.993% |
Brainstorm Cell | -5.760% | -2.456% | -5.429% | -82.011% | 114.009% | -83.450% | - |
Comments
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for TNXP provided by MarketBeat